Stay updated on TAK-861 in Narcolepsy Type 1 Clinical Trial

Sign up to get notified when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-861 in Narcolepsy Type 1 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website’s revision tag updated from Revision: v3.5.3 to Revision: v3.5.4, indicating a patch-level update. The old revision text was removed and the new one is now displayed to reflect the change.
    Difference
    0.0%
    Check dated 2026-05-14T22:29:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3. This reflects a newer version of the page's metadata rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-04-30T16:30:55.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added. Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-18T18:07:23.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:48:01.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added the 2026 JAMA Neurology citation for Oveporexton and removed the 2025 ahead-of-print citation for the same article.
    Difference
    0.0%
    Check dated 2026-03-04T13:01:24.000Z thumbnail image

Stay in the know with updates to TAK-861 in Narcolepsy Type 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.